Retrospective multicenter clinical study of risk factors for cetuximab-related infusion reaction in Japanese patients
Not Applicable
- Conditions
- Colorectal Cancer, Head and Neck Cancer
- Registration Number
- JPRN-jRCT1040210116
- Lead Sponsor
- Onoda Chiharu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 244
Inclusion Criteria
Over 20 years old,Japanese, the first administration of cetuximab with chemotherapy or alone
Exclusion Criteria
The patients who have allergic reaction during chemotherapy administration on the same day
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The exploratory factor analysis of the risk of cetuximab-related infusion reaction
- Secondary Outcome Measures
Name Time Method the rate of cetuximab-related infusion reaction<br>the percentage of infusion reaction onsets according to adverse event-grades<br>the percentage of medical interventions according to adverse event-grades